Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung-Feng Huang

Showing results (51-60 of 286) with videos related to

Pageof 29
Sort By:
The Kaohsiung Journal of Medical Sciences|November 17, 2016
Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter studyMing-Lun Yeh, Ching-I Huang, Ming-Yen Hsieh, et al.
International Journal of Medical Sciences|April 2, 2014
Discrepancy between serological and virological analysis of viral hepatitis in hemodialysis patientsJer-Ming Chang, Chung-Feng Huang, Szu-Chia Chen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Advantage of clinical colchicine concentration to promote sorafenib or regorafenib anti-cancer effects on hepatocellular carcinomaZu-Yau Lin, Ming-Lun Yeh, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|June 12, 2017
Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infectionTa-Ya Lin, Ming-Lun Yeh, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|June 6, 2025
A Point-of-Care Model for Hepatitis C Elimination in Remote Islands of TaiwanTzu-Chun Lin, Pei-Chien Tsai, Chung-Feng Huang, et al.
Journal of Gastroenterology and Hepatology|December 12, 2013
Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infectionChing-I Huang, Chung-Feng Huang, Jee-Fu Huang, et al.
The Kaohsiung Journal of Medical Sciences|May 16, 2019
Integrated care for methadone maintenance patients with hepatitis C virus infectionChi-Ming Tai, Yung-Chieh Yen, Ming-Jong Bair, et al.
Journal of the Chinese Medical Association : JCMA|March 7, 2019
Elevated serum ferritin level associated with hepatic steatosis and fibrosis in hepatitis C virus-infected patientsBatbold Batsaikhan, Gantsetseg Gantumur, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|January 16, 2025
Hepatitis C virus-free endoscope procedures project: An in-hospital elimination approachBenjamin Lih-Ren Hsieh, Yen-Ting Kuo, Yu-Ju Wei, et al.
Journal of Gastroenterology and Hepatology|June 23, 2018
Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradicationChung-Feng Huang, Shu-Chi Wang, Ming-Lun Yeh, et al.
Pageof 29

Showing results (51-60 of 286) with videos related to

Sort By:
Pageof 29
The Kaohsiung Journal of Medical Sciences|November 17, 2016
Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter studyMing-Lun Yeh, Ching-I Huang, Ming-Yen Hsieh, et al.
International Journal of Medical Sciences|April 2, 2014
Discrepancy between serological and virological analysis of viral hepatitis in hemodialysis patientsJer-Ming Chang, Chung-Feng Huang, Szu-Chia Chen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Advantage of clinical colchicine concentration to promote sorafenib or regorafenib anti-cancer effects on hepatocellular carcinomaZu-Yau Lin, Ming-Lun Yeh, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|June 12, 2017
Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infectionTa-Ya Lin, Ming-Lun Yeh, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|June 6, 2025
A Point-of-Care Model for Hepatitis C Elimination in Remote Islands of TaiwanTzu-Chun Lin, Pei-Chien Tsai, Chung-Feng Huang, et al.
Journal of Gastroenterology and Hepatology|December 12, 2013
Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infectionChing-I Huang, Chung-Feng Huang, Jee-Fu Huang, et al.
The Kaohsiung Journal of Medical Sciences|May 16, 2019
Integrated care for methadone maintenance patients with hepatitis C virus infectionChi-Ming Tai, Yung-Chieh Yen, Ming-Jong Bair, et al.
Journal of the Chinese Medical Association : JCMA|March 7, 2019
Elevated serum ferritin level associated with hepatic steatosis and fibrosis in hepatitis C virus-infected patientsBatbold Batsaikhan, Gantsetseg Gantumur, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|January 16, 2025
Hepatitis C virus-free endoscope procedures project: An in-hospital elimination approachBenjamin Lih-Ren Hsieh, Yen-Ting Kuo, Yu-Ju Wei, et al.
Journal of Gastroenterology and Hepatology|June 23, 2018
Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradicationChung-Feng Huang, Shu-Chi Wang, Ming-Lun Yeh, et al.
Pageof 29